Immunicon Overview

  • Founded
  • 1984
  • Status
  • Acquired/​Merged
  • Employees
  • 96
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $31M
Latest Deal Amount

Immunicon General Information


Developer and manufacturer of cell-based diagnostic and research products. The company manufactures ultra-high sensitive cancer detection test kits (cancer blood test) and next generation cell analysis instruments (cell track cytometer) for various research and clinical applications.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Diagnostic Equipment
Discovery Tools (Healthcare)
Primary Office
  • 3401 Masons Mill Road
  • Suite 100
  • Huntingdon Valley, PA 19006
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunicon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Aug-2008 $31M 0000 Completed Generating Revenue/Not Profitable
6. Bankruptcy: Admin/Reorg 11-Jun-2008 Completed Bankruptcy: Admin/Reorg
5. IPO 16-Apr-2004 000.00 Completed Generating Revenue
4. Later Stage VC (Series F) 01-Jul-2003 000.00 000.00 Completed Generating Revenue
3. Later Stage VC 01-Jan-2002 000.00 000.00 Completed Generating Revenue
2. Later Stage VC 11-Sep-2000 $21.8M $31.8M Completed Generating Revenue
1. Later Stage VC (Series D) 01-Jan-1999 $10M $10M Completed Generating Revenue
To view Immunicon’s complete valuation and funding history, request access »

Immunicon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunicon Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Anthem Capital Management Venture Capital Minority 000 0000 000000 0
Burrill & Co Merchant Banking Firm Minority 000 0000 000000 0
Canaan Partners Venture Capital Minority 000 0000 000000 0
Claneil Enterprises Holding Company Minority 000 0000 000000 0
Equity4Life Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »